Tatty
22 May 2018
Re: Seed No commercial details but at least this should give the so a kick up the .......
mol42
22 May 2018
Re: Seed Discussions successfully concludedOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces that it has entered into a non-exclusive agreement with Seed Health ('SeedTM') to produce, promote, market, and commercialise products containing LP-LDL® in the USA. OptiBiotix previously announced (RNS: 1 May 2018) that it was in commercial discussions with SeedTM in response to media reports on the launch of its LP-LDL® product in the USA.This announcement confirms the successful conclusion of those discussions.Always great to have things finally confirmed and ahead of results tomorrowmol
caraldo
21 May 2018
video [link]
elrico63
20 May 2018
Re: Seed launch Mol - I have been very critical of the perceived role Seed Health have played in the leaking of two articles, linked to there launch. IMHO they have not covered themselves in glory. The business Insider was pulled, no Vogue, both within hours of me contacting SOH about them. Coincidental? I portion no blame to OPTI BOD, if they have been instrumental in having the articles removed, they have done so to protect their business and professional contact in the eyes's of investors and regulators. However, yet another article emerges, this time co-founder Raja Dhir. See extract, which clearly suggests a launch next month. OK, no specific ref to OPTI or it's probiotic, unlike the business insider article which pointed readers to the scientific abstract which ref's OPTI. [link] you jump to the conclusion that all prebiotics are bad, Raja Dhir, the co-founder and co-CEO of the new microbiome startup Seed, launching next month, says not all prebiotics are the same. “One of the most exciting new developments in microbiome research is looking at novel non-fermentable prebiotics and how they are converted into health-promoting compounds (metabolites) by the gut microbiota,” he says. [link]
mol42
19 May 2018
Re: Seed launch - Vouge The entrepreneur Ara Katz would like to clear a few things up. All probiotics are not created equal, and some products touting “probiotic” labels aren’t probiotics at all. Katz is seated at the whitewashed Venice headquarters of her latest venture, Seed, an innovative consumer-health company focused on the microbiome of the gut that is poised to shake up the wellness industry when it launches its own novel take on the supplement—one based on hard science and developed by the leading minds in the field—next week.“Probiotic popcorn and probiotic chocolate . . . people claim that every single food they grow bacteria in is somehow a probiotic,” Katz continues. “A few may [be], but in order to be a probiotic, a live microbe must be studied and shown to have health benefits.” Disturbed by the amount of misinformation and gimmickry surrounding the wildly popular category of probiotic health supplements, which is projected to exceed $64 billion by 2023, she has been on a mission to cut through the proverbial “well-washing” since 2016.That’s when Katz, a successful fashion entrepreneur who launched companies such as the revolutionary but now defunct e-commerce group BeachMint (of StyleMint fame) and the LVMH-backed shopping start-up Spring, and held advising roles for powerhouse brands from Violet Grey to Tamara Mellon, found herself unexpectedly plunged headlong into the business of probiotics. Not long after giving birth to her son Pax, she recalls, she started to have trouble creating enough breast milk. Like many new mothers, she considered formula, which led her to research what exactly an infant needs for proper development, which eventually landed her on the human microbiome. “The way that women end up learning about their body is through pathology or pregnancy,” she says, shaking her head at the delayed process of self-discovery.Soon, Katz had teamed up with scientist Raja Dhir to create one straightforward and scientifically sound pill that would combine the best of probiotics and prebiotics (a combination formally known as a synbiotic). For the task, they also enlisted chief scientist Dr. Gregor Reid, coauthor of the scientific definition of probiotics for the U.N. and World Health Organization in 2001.“We are only half human,” insists Katz, whose hip-grazing waves, makeup-free razor-sharp jawline, and sea-glass green eyes are argument enough for taking care of our other halves—the approximately 38 trillion microorganisms (bacteria, viruses, and fungi) taking transient residence on and inside us at any given moment. Seed’s daily Synbiotic for women includes 24 potent strains of bacteria that have been clinically proven to not only ease digestion and significantly increase folate production, but to also contribute to cardiovascular health and improve dermatological health. There is an accompanying male-focused formula as well, and both are painstakingly formulated with plant-based prebiotic compounds from sources rich in probiotic-feeding polyphenols including Indian pomegranate, which is capable of converting to cell-cleansing and muscle-recovery assisting urolithin A. “We took a research-first approach,” says Dhir, who outfitted the company’s superstar advisory board with members of the White House’s Human Microbiome Project and lead researchers from Harvard, MIT, and Baylor College of Medicine.The finished product will debut on Monday and be available for order from the company’s website, a month’s supply housed in a handsome apothecary-green jar with an accompanying travel vial shipped right to your door. And it’s only the first of many health contributions on Seed’s horizon. “Things like reinventing infant formula are on our roadmap,” says Katz. “We’re thinking about vaginal health and women’s health, and mother and infant health, too.” With the microbiome, the possibilities are only just making themselves known—and Dhir and Katz are funding their own clinical trials to help encourage development. “I w
elrico63
19 May 2018
Re: Seed launch - Vouge This is part of the problem PI's have with OPTI. It requires extensive reading; new science, development of new products, business strategy, etc. It's a big learning curve for most people. It took me months to get to grips with it.The Vogue article has been pulled, same as the business article was a couple of weeks ago. It seems Seed Health have a leaky ship and did show due respect to OPTI by clearing it with them.
RedNoseRudolf
19 May 2018
Re: Seed launch - Vouge Thanks elrico. I thought I was getting some of the detailed stuff but it quickly went way over my head.
elrico63
18 May 2018
Re: Seed launch - Vouge Ignore the date of the following article.[link] the article, a link which takes you to the science bit...no pun intended.[link] Kolida is one of the scientists. I'm sure you are aware of who she is and her link to OPTI.Near the foot of the page;Funding StatementThis study was supported by Optibiotix Health plc. Optibiotix Health plc provided support in the form of salary for author Sofia Kolida, as well as the probiotic used within this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
RedNoseRudolf
18 May 2018
Re: Seed launch - Vouge Interesting article but does this product to be launched Monday involve OPTI ? The names and timing coincide with the 1/5 RNS but no explicit connection.
elrico63
18 May 2018
Seed launch - Vouge [link]
elrico63
18 May 2018
Industry award x2 At the risk of telling you how to suck an egg I'm sure it won't be lost on many how important the award, (second) will prove for the commercial development of SlimBiome. There will have been many potential partners at Vitafood seeking out such a product to complement their range, for a healthier drive and boost their sale-ability and drive for profits. They will have noted 2 awards are not handed out by PR people, but by panelists with a background in the industry. Of course, the added bonus, SlimBiome is backed by independently verified strong science. These points will have acted like a hungry beers to salmon in a shallow river.Independent human studies by Oxford Brookes University have demonstrated that if you compare control and test groups who take SlimBiome® or a placebo, the SlimBiome® group: - · Feel fuller and are less hungry· Have less food cravings· Change their food choice so eat less sweet or fatty foods This contrasts with current products on the market which often lack strong scientific evidence or clinical studies and typically rely on customers' self-control to restrict calories and as a consequence have a high failure rate. Independent consumer studies have shown that 100% of customers who used SlimBiome® in OptiBiotix's GoFigure® products lost weight, on average 2-3lbs per week. Most importantly these customers found the products relieve hunger pangs leading to easier dieting.The award for Weight Management Ingredient of the Year at Vitafoods is the second industry award for SlimBiome®, following on from winning the award for 'Best Functional Ingredient for Health and Well Being' at Food Matters in November 2017.
mol42
17 May 2018
Probiotic Winner website[link] have a try at switzerland companies registry re any financial info but after a few minutes thought better of wasting my time - lolstill nowt re seed.com eithernevermind still onwards in opti spacemol
elrico63
17 May 2018
Commercial progress I have put together an itinerary of partnership agreements, dates, global footprint and estimated revenues based on size of company; small, medium and large. TW used part of this in one of his updates...credibility of sorts, but more importantly, agreeable with SOH and liked on Twitter by OPTI.Simple format[link]
alpal
17 May 2018
Re: Holdings RNS Assuming YSF got in prior to 2016 they have done quite well. But the share price has been on a gradual down-trend since then. About 90p then to 70p now.For me, the disappointment is that YSF are clearly not expecting any great improvement in results soon [but plenty of 'jam tomorrow'] or they wouldn't be selling.
mol42
16 May 2018
Holdings RNS no surprise YSF continue to realise some of their initial investment and no doubt will continue to do sohowever they are doing so on a responsible and a manageable basis as far as i'm concerned (i've only gone back to mar 17)march 17 sold 1.5m to 10499314may 17 from there sold 500k to 9999313may 18 from there sold 550k to 9449314 mol
